Polypharmacy and risk of admission to hospital in people ageing with HIV: what is the contribution of drug–drug interactions?

• Clotilde Allavena,
• Catia Marzolini

Affiliations

Clotilde Allavena

Department of Infectious Diseases, Hôtel Dieu CHU Nantes, INSERM UIC 1413, France

Catia Marzolini

Division of Infectious Diseases and Hospital Epidemiology, Department of Medicine and Department of Clinical Research, University Hospital of Basel and University of Basel, Switzerland; Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, UK